
Published On: Aug 2023
Published On: Aug 2023
According to Business Market Insights research, the Middle East & Africa cardiac microcatheter market was valued at US$ 14.86 million in 2023 and is expected to reach US$ 19.10 million by 2028, registering a CAGR of 5.2% from 2023 to 2028. High prevalence of cardiovascular diseases and growing use of percutaneous coronary intervention (PCI) for treating chronic total occlusions (CTO) are the critical factors attributed to the Middle East & Africa cardiac microcatheter market expansion.
In 2019, according to the Institute for Health Metrics and Evaluation, ischemic heart disease is the leading cause of death in the UAE. The American Heart Association and the Emirates Cardiac Society (ECS) have established hospital certifications in the Middle East for quality, guideline-based care to improve outcomes for patients suffering from acute ST-elevation myocardial infarction (STEMI). STEMI is a severe form of a heart attack wherein a coronary artery is entirely blocked, failing the considerable part of the heart muscle to receive blood, often resulting in permanent damage and an increased risk of death. The Emirates Cardiac Society helps improve cardiovascular health through education, research, and quality patient care. Africa records one of the highest prevalence of heart disease, including congenital heart disease (CHD) and rheumatic heart disease (RHD), in children and young adults. Over the past decade, several important centers, and collaborations, such as the Salam Centre for cardiac surgery, the Walter Sisulu Paediatric Centre for Africa, and others, have emerged to address these differences, and renewed attention has been focused on the early detection and treatment of CHD while promoting innovative approaches and training centers for excellence. Therefore, increasing healthcare spending and government-led initiatives regarding heart health are expected to provide an opportunity for the market growth in the coming years.
On the contrary, complications and failures related to usage of cardiac microcatheters hampers the Middle East & Africa Cardiac Microcatheter Market.
Based on indication, the Middle East & Africa cardiac microcatheter market is segmented into general peripheral vascular and coronary. The coronary segment held 58.4% share of Middle East & Africa Cardiac Microcatheter Market in 2023, amassing US$ 8.68 million. It is projected to garner US$ 11.25 million by 2028 to expand at 5.3% CAGR during 2023–2028.
Based on end user, the Middle East & Africa cardiac microcatheter market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held 46.1% share of Middle East & Africa Cardiac Microcatheter Market in 2023, amassing US$ 6.84 million. It is projected to garner US$ 8.94 million by 2028 to expand at 5.5% CAGR during 2023–2028.
Based on country, the Middle East & Africa cardiac microcatheter market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 34.9% share of Middle East & Africa Cardiac Microcatheter Market in 2023. It was assessed at US$ 5.18 million in 2023 and is likely to hit US$ 6.82 million by 2028, exhibiting a CAGR of 5.7% during the forecast period.
Key players dominating the Middle East & Africa cardiac microcatheter market are Boston Scientific Corp; Integer Holdings Corp; Medtronic Plc; Merit Medical Systems Inc; Nipro Corp; Teleflex Inc; and Terumo Corp, among others.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com